Japan
· Delayed Price · Currency is JPY Takara Bio Statistics
Total Valuation
Takara Bio has a market cap or net worth of JPY 134.50 billion. The enterprise value is 94.88 billion.
| Market Cap | 134.50B |
| Enterprise Value | 94.88B |
Important Dates
The last earnings date was Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Takara Bio has 120.42 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 120.42M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 10.75% |
| Float | 45.11M |
Valuation Ratios
The trailing PE ratio is 147.97 and the forward PE ratio is 33.89.
| PE Ratio | 147.97 |
| Forward PE | 33.89 |
| PS Ratio | 3.05 |
| PB Ratio | 1.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 38.75 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.93, with an EV/FCF ratio of 27.34.
| EV / Earnings | 104.38 |
| EV / Sales | 2.15 |
| EV / EBITDA | 13.93 |
| EV / EBIT | 47.23 |
| EV / FCF | 27.34 |
Financial Position
The company has a current ratio of 9.51
| Current Ratio | 9.51 |
| Quick Ratio | 7.32 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 95.67 |
Financial Efficiency
Return on equity (ROE) is 0.83% and return on invested capital (ROIC) is 1.10%.
| Return on Equity (ROE) | 0.83% |
| Return on Assets (ROA) | 1.01% |
| Return on Capital (ROIC) | 1.10% |
| Revenue Per Employee | 24.02M |
| Profits Per Employee | 494,559 |
| Employee Count | 1,838 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.91% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -7.91% |
| 50-Day Moving Average | 1,030.16 |
| 200-Day Moving Average | 1,051.59 |
| Relative Strength Index (RSI) | 63.62 |
| Average Volume (20 Days) | 263,675 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Takara Bio had revenue of JPY 44.15 billion and earned 909.00 million in profits. Earnings per share was 7.55.
| Revenue | 44.15B |
| Gross Profit | 26.01B |
| Operating Income | 2.01B |
| Pretax Income | 1.69B |
| Net Income | 909.00M |
| EBITDA | 6.81B |
| EBIT | 2.01B |
| Earnings Per Share (EPS) | 7.55 |
Balance Sheet
| Cash & Cash Equivalents | 39.96B |
| Total Debt | n/a |
| Net Cash | 39.96B |
| Net Cash Per Share | 331.83 |
| Equity (Book Value) | 116.15B |
| Book Value Per Share | 961.83 |
| Working Capital | 57.06B |
Cash Flow
In the last 12 months, operating cash flow was 5.72 billion and capital expenditures -2.25 billion, giving a free cash flow of 3.47 billion.
| Operating Cash Flow | 5.72B |
| Capital Expenditures | -2.25B |
| Free Cash Flow | 3.47B |
| FCF Per Share | 28.83 |
Margins
Gross margin is 58.91%, with operating and profit margins of 4.55% and 2.06%.
| Gross Margin | 58.91% |
| Operating Margin | 4.55% |
| Pretax Margin | 3.83% |
| Profit Margin | 2.06% |
| EBITDA Margin | 15.43% |
| EBIT Margin | 4.55% |
| FCF Margin | 7.86% |
Dividends & Yields
This stock pays an annual dividend of 17.00, which amounts to a dividend yield of 1.56%.
| Dividend Per Share | 17.00 |
| Dividend Yield | 1.56% |
| Dividend Growth (YoY) | -59.52% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 225.63% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 1.56% |
| Earnings Yield | 0.68% |
| FCF Yield | 2.58% |
Stock Splits
The last stock split was on March 29, 2011. It was a forward split with a ratio of 400.
| Last Split Date | Mar 29, 2011 |
| Split Type | Forward |
| Split Ratio | 400 |
Scores
Takara Bio has an Altman Z-Score of 10.34.
| Altman Z-Score | 10.34 |
| Piotroski F-Score | n/a |